Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

NDORMS have been successful with 3 Clinical Trials (BioPatch, MANTIS and NINJA) being awarded.

BioPatch

NIHR i4i committee has approved Prof Andrew Carr’s application entitled “A novel electrospun patch to augment rotator cuff tendon repair” - Oxford BioPatch. The Oxford Biopatch is an innovative solution for rotator cuff repair which promotes rapid regrowth of tendon tissue and could transform the success of shoulder repair operations. Speaking about the award Prof Carr stated that “The monies from the NIHR are invaluable to investigate whether a nanofiber surgical patch invented in Oxford can improve the outcome of surgery for tendon repair in the shoulder and we are looking forward to discovering if the technology can improve patient recovery”.

MANTIS

NIHR HTA committee has approved Prof Sion Glyn-Jones application entitled “Managing Avascular Necrosis Treatments: An Interventional Study” MANTIS. This will be looking at the debilitating affect that Avascular Necrosis (AVN) of the hip occurs in younger people and how this may be managed by an effective drug treatment. Lead Researcher Prof Sion Glyn Jones states that “With this support from NIHR we have the opportunity to find an effective drug treatment for this condition could improve the quality of life for thousands of young people”

NINJA

NIHR RfPB committee has approved Prof Abhilash Jain and his application entitled “Nail Injury Analysis Trial” NINJA. This will be looking into childrens’ fingertip injuries which is the most common surgically treated paediatric hand injury with 10,000 operations performed every year in the UK. Despite this there are no published randomized controlled trials (RCT) looking at surgical interventions and NINJA is the first multi-centre RCT looking at ways to improve surgical outcomes in these patients. On receiving confirmation of the award Prof Jain stated “This award from NIHR will allow us to evaluate two differing repair techniques with the intention of advising best practice to clinicians for future Injuries”.

Our Team

Further Information on the Trials

Similar stories

New Botnar Research Institute Director starts today

Professor Jonathan Rees begins his new role as Director of the Botnar Research Institute today, taking over from Professor Andrew Carr.

Patient and public involvement in Rheumatology research – embracing the wave of change

On launching the new OPEN ARMS PPI group in Oxford, Dr. Laura Coates explored the patient and public involvement (PPI) models of three academic centres in the UK to show how it benefits researchers, clinicians, and patients alike.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

NDORMS joins research partnership to understand links between overlapping long-term conditions

The links between different long-term health conditions will be explored in new research funded with a £2.5million grant from the Medical Research Council.

NDORMS researchers awarded grant for study on the effects of COVID-19 vaccines on long COVID

A team of NDORMS researchers including Doctor Annika Jödicke and Doctor Victoria Strauss have been awarded NIHR funding to carry out a study into the effects of different COVID-19 vaccines on long COVID.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.